Rocco Venezia - Net Worth and Insider Trading
Rocco Venezia Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rocco Venezia owns 1 companies in total, including Intercept Pharmaceuticals Inc (ICPT) .
Rocco Venezia Trading Performance
Rocco Venezia Ownership Network
Ownership Network List of Rocco Venezia
Ownership Network Relation of Rocco Venezia
Rocco Venezia Owned Company Details
What does Intercept Pharmaceuticals Inc do?
Intercept Pharmaceuticals Inc is a biotech company focused on developing and commercializing novel therapeutics to treat progressive non-viral liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor. OCA was approved as Ocaliva to treat primary biliary cirrhosis in 2016 and is being developed for a variety of chronic liver diseases, including nonalcoholic steatohepatitis, or NASH.
Who are the key executives at Intercept Pharmaceuticals Inc?
Rocco Venezia is the Chief Accounting Officer of Intercept Pharmaceuticals Inc. Other key executives at Intercept Pharmaceuticals Inc include EVP & Chief Financial Officer Andrew Saik , President & R&D and CMO M Michelle Berrey , and SVP & IR & Corp. Affairs Lisa Defrancesco .
Intercept Pharmaceuticals Inc (ICPT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Intercept Pharmaceuticals Inc (ICPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intercept Pharmaceuticals Inc (ICPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Intercept Pharmaceuticals Inc (ICPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intercept Pharmaceuticals Inc Insider Transactions
Rocco Venezia Mailing Address
Above is the net worth, insider trading, and ownership report for Rocco Venezia. You might contact Rocco Venezia via mailing address: C/o Intercept Pharmaceuticals, Inc., 10 Hudson Yards, 37th Floor, New York Ny 10001.